Anticancer therapy

Norenberg, Jeffrey P.

Advanced Search OptionsAdvanced Search queries use a traditional Term Search. For more info, see our FAQ.

All Fields:

Patent Title:

Abstract:

Assignee:

Inventor(s):

Patent Number:

Patent Classification (CPC):

All Classifications
A - human necessities
A01 - agriculture
A21 - baking
A22 - butchering
A23 - foods or foodstuffs
A24 - tobacco
A41 - wearing apparel
A42 - headwear
A43 - footwear
A44 - haberdashery
A45 - hand or travelling articles
A46 - brushware
A47 - furniture
A61 - medical or veterinary science
A62 - life-saving
A63 - sports
A99 - subject matter not otherwise provided for in this section
B - performing operations
B01 - physical or chemical processes or apparatus in general
B02 - crushing, pulverising, or disintegrating
B03 - separation of solid materials using liquids or using pneumatic tables or jigs
B04 - centrifugal apparatus or machines for carrying-out physical or chemical processes
B05 - spraying or atomising in general
B06 - generating or transmitting mechanical vibrations in general
B07 - separating solids from solids
B08 - cleaning
B09 - disposal of solid waste
B21 - mechanical metal-working without essentially removing material
B22 - casting
B23 - machine tools
B24 - grinding
B25 - hand tools
B26 - hand cutting tools
B27 - working or preserving wood or similar material
B28 - working cement, clay, or stone
B29 - working of plastics
B30 - presses
B31 - making articles of paper, cardboard or material worked in a manner analogous to paper
B32 - layered products
B33 - additive manufacturing technology
B41 - printing
B42 - bookbinding
B43 - writing or drawing implements
B44 - decorative arts
B60 - vehicles in general
B61 - railways
B62 - land vehicles for travelling otherwise than on rails
B63 - ships or other waterborne vessels
B64 - aircraft
B65 - conveying
B66 - hoisting
B67 - opening, closing {or cleaning} bottles, jars or similar containers
B68 - saddlery
B81 - microstructural technology
B82 - nanotechnology
B99 - subject matter not otherwise provided for in this section
C - chemistry
C01 - inorganic chemistry
C02 - treatment of water, waste water, sewage, or sludge
C03 - glass
C04 - cements
C05 - fertilisers
C06 - explosives
C07 - organic chemistry
C08 - organic macromolecular compounds
C09 - dyes
C10 - petroleum, gas or coke industries
C11 - animal or vegetable oils, fats, fatty substances or waxes
C12 - biochemistry
C13 - sugar industry
C14 - skins
C21 - metallurgy of iron
C22 - metallurgy
C23 - coating metallic material
C25 - electrolytic or electrophoretic processes
C30 - crystal growth
C40 - combinatorial technology
C99 - subject matter not otherwise provided for in this section
D - textiles
D01 - natural or man-made threads or fibres
D02 - yarns
D03 - weaving
D04 - braiding
D05 - sewing
D06 - treatment of textiles or the like
D07 - ropes
D10 - indexing scheme associated with sublasses of section d, relating to textiles
D21 - paper-making
D99 - subject matter not otherwise provided for in this section
E - fixed constructions
E01 - construction of roads, railways, or bridges
E02 - hydraulic engineering
E03 - water supply
E04 - building
E05 - locks
E06 - doors, windows, shutters, or roller blinds in general
E21 - earth drilling
E99 - subject matter not otherwise provided for in this section
F - mechanical engineering
F01 - machines or engines in general
F02 - combustion engines
F03 - machines or engines for liquids
F04 - positive - displacement machines for liquids
F05 - indexing schemes relating to engines or pumps in various subclasses of classes f01-f04
F15 - fluid-pressure actuators
F16 - engineering elements and units
F17 - storing or distributing gases or liquids
F21 - lighting
F22 - steam generation
F23 - combustion apparatus
F24 - heating
F25 - refrigeration or cooling
F26 - drying
F27 - furnaces
F28 - heat exchange in general
F41 - weapons
F42 - ammunition
F99 - subject matter not otherwise provided for in this section
G - physics
G01 - measuring
G02 - optics
G03 - photography
G04 - horology
G05 - controlling
G06 - computing
G07 - checking-devices
G08 - signalling
G09 - education
G10 - musical instruments
G11 - information storage
G12 - instrument details
G16 - information and communication technology [ict] specially adapted for specific application fields
G21 - nuclear physics
G99 - subject matter not otherwise provided for in this section
H - electricity
H01 - basic electric elements
H02 - generation
H03 - basic electronic circuitry
H04 - electric communication technique
H05 - electric techniques not otherwise provided for
H99 - subject matter not otherwise provided for in this section
Y - new / cross sectional technologies
Y02 - technologies or applications for mitigation or adaptation against climate change
Y04 - information or communication technologies having an impact on other technology areas
Y10 - technical subjects covered by former uspc

More Options ...

Title: Anticancer therapy

Abstract

A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.

Inventors:: Norenberg, Jeffrey P.

Issue Date:: Tue Jan 08 00:00:00 EST 2019

Research Org.:: STC.UNM, Albuquerque, NM (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1496591

Patent Number(s):: 10172967

Application Number:: 15/427,355

Assignee:: STC.UNM (Albuquerque, NM)

Patent Classifications (CPCs):: A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

Show more

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K2300/00 - Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
A61K31/7068 - having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
A61K38/31 - Somatostatins
A61K45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K51/08 - Peptides, e.g. proteins {, carriers being peptides, polyamino acids, proteins}
A61K51/083 - {the peptide being octreotide or a somatostatin-receptor-binding peptide}
A61K51/088 - {conjugates with carriers being peptides, polyamino acids, proteins

Show less

DOE Contract Number:: FG01-001NE23554

Resource Type:: Patent

Resource Relation:: Patent File Date: 2017 Feb 08

Country of Publication:: United States

Language:: English

Subject:: 60 APPLIED LIFE SCIENCES

Citation Formats


                    Norenberg, Jeffrey P. Anticancer therapy.  United States: N. p., 2019. 
        Web.

Copy to clipboard


                    Norenberg, Jeffrey P. Anticancer therapy.  United States.

Copy to clipboard


                    Norenberg, Jeffrey P. Tue .  
        "Anticancer therapy".  United States.  https://www.osti.gov/servlets/purl/1496591.

Copy to clipboard


                    
@article{osti_1496591,

  title        = {Anticancer therapy},

  author       = {Norenberg, Jeffrey P.},

  abstractNote = {A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {Tue Jan 08 00:00:00 EST 2019},

  month        = {Tue Jan 08 00:00:00 EST 2019}

}

Copy to clipboard

Patent:

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Treatment of damaged bone marrow and dosage units therefor
patent, July 1990

Borch, Richard F.; Schmalbach, Therese K.
US Patent Document 4,938,949
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4938949

Preclinical Evaluation of the α-Particle Generator Nuclide ²²⁵Ac for Somatostatin Receptor Radiotherapy of Neuroendocrine Tumors
journal, June 2008

Miederer, M.; Henriksen, G.; Alke, A.
Clinical Cancer Research, Vol. 14, Issue 11, p. 3555-3561
https://doi.org/10.1158/1078-0432.CCR-07-4647

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
journal, November 2009

Rolleman, Edgar; Melis, Marleen; Valkema, Roelf
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 37, Issue 5, p. 1018-1031
https://doi.org/10.1007/s00259-009-1282-y

Somatostatin in the central nervous system: Physiology and pathological modifications
journal, January 1986

Epelbaum, Jacques
Progress in Neurobiology, Vol. 27, Issue 1
https://doi.org/10.1016/0301-0082(86)90012-2

Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
journal, August 2003

Reubi, Jean Claude
Endocrine Reviews, Vol. 24, Issue 4
https://doi.org/10.1210/er.2002-0007

Biochemical and Functional Properties of Somatostatin Receptors
journal, June 1992

Rens-Domiano, Stephanie; Reisine, Terry
Journal of Neurochemistry, Vol. 58, Issue 6
https://doi.org/10.1111/j.1471-4159.1992.tb10938.x

Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues
journal, July 2009

de Jong, Marion; Breeman, Wout; Kwekkeboom, Dik
Accounts of Chemical Research, Vol. 42, Issue 7, p. 873-880
https://doi.org/10.1021/ar800188e

Long-term toxicity of [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate in rats
journal, September 2006

Rolleman, Edgar; Krenning, Eric; Bernard, Bert
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Issue 2, p. 219-227
https://doi.org/10.1007/s00259-006-0232-1

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
journal, January 1973

Brazeau, P.; Vale, W.; Burgus, R.
Science, Vol. 179, Issue 4068
https://doi.org/10.1126/science.179.4068.77

Hypothalamic hormones: from neuroendocrinology to cancer therapy
journal, January 1994

Schally, Andrew V.
Anti-Cancer Drugs, Vol. 5, Issue 2
https://doi.org/10.1097/00001813-199404000-00001

Cloning, Functional Expression and Pharmacological Characterization of a Fourth (hSSTR4) and a Fifth (hSSTR5) Human Somatostatin Receptor Subtype
journal, September 1993

Yamada, Y.; Kagimoto, S.; Kubota, A.
Biochemical and Biophysical Research Communications, Vol. 195, Issue 2
https://doi.org/10.1006/bbrc.1993.2122

The clinical value of [⁹⁰Y-DOTA]-D-Phe¹-Tyr³-octreotide (⁹⁰Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
journal, July 2001

Waldherr, C.; Pless, M.; Maecke, H.
Annals of Oncology, Vol. 12, Issue 7, p. 941-945
https://doi.org/10.1023/A:1011160913619

RGD (Arg-Gly-Asp) coupled to (neuro)peptides
patent, April 2007

DeJong, Marion; Krenning, Eric P.; Van Hagen, Petrus Martinus
US Patent Document 7,202,330
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7202330

Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study
journal, July 1996

Gibril, Fathia
Annals of Internal Medicine, Vol. 125, Issue 1
https://doi.org/10.7326/0003-4819-125-1-199607010-00005

A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides
journal, April 1993

Corness, Jacquie D.; Demchyshyn, Lidia L.; Seeman, Philip
FEBS Letters, Vol. 321, Issue 2-3
https://doi.org/10.1016/0014-5793(93)80124-D

Somatostatin analogs for the treatment of cancer
patent, November 2001

Burman, Anand C.; Prasad, Sudhanand; Mukherjee, Rama
US Patent Document 6,316,414
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6316414

Cyclic peptide somatostatin analogs
patent, August 1999

Dean, Richard T.; McBride, William; Lister-James, John
US Patent Document 5,932,189
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5932189

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
journal, March 1986

Cai, R. Z.; Szoke, B.; Lu, R.
Proceedings of the National Academy of Sciences, Vol. 83, Issue 6
https://doi.org/10.1073/pnas.83.6.1896

Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines
journal, May 1999

Tolis, C.; Peters, G. J.; Ferreira, C. G.
European Journal of Cancer, Vol. 35, Issue 5
https://doi.org/10.1016/S0959-8049(98)00425-0

Conformationally constrained backbone cyclized somatostatin analogs
patent, April 2000

Hornik, Vered; Gellerman, Gary; Afargan, Mich El M.
US Patent Document 6,051,554
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6051554

Clinical results of long‐term slow‐release lanreotide treatment of acromegaly
journal, April 1997

Giusti, M.; Ciccarelli, E.; Dallabonzana, D.
European Journal of Clinical Investigation, Vol. 27, Issue 4
https://doi.org/10.1046/j.1365-2362.1997.1190659.x

Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions
patent, June 1995

Gansow, Otto A.; Brechbiel, Martin W.; Magerstadt, Michael
US Patent Document 5,428,154
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5428154

A potent cyclic hexapeptide analogue of somatostatin
journal, July 1981

Veber, Daniel F.; Freidinger, Roger M.; Perlow, Debra Schwenk
Nature, Vol. 292, Issue 5818
https://doi.org/10.1038/292055a0

In vitro detection of somatostatin receptors in human tumors
journal, September 1992

Reubi, J. C.; Krenning, E.; Lamberts, S. W. J.
Metabolism, Vol. 41, Issue 9
https://doi.org/10.1016/0026-0495(92)90042-9

Bifunctional chelating agents
patent, October 1991

Johnson, David K.; Kline, Steven J.
US Patent Document 5,057,302
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5057302

Treatment with ⁹⁰Y- and ¹⁷⁷Lu-DOTATOC in patients with metastatic neuroendocrine tumors
journal, December 2006

Frilling, Andrea; Weber, Frank; Saner, Fuat
Surgery, Vol. 140, Issue 6, p. 968-977
https://doi.org/10.1016/j.surg.2006.07.030

Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
journal, January 1998

Wermuth, C. G.; Ganellin, C. R.; Lindberg, P.
Pure and Applied Chemistry, Vol. 70, Issue 5
https://doi.org/10.1351/pac199870051129

Experimental facts supporting a red marrow uptake due to radiometal transchelation in ⁹⁰Y-DOTATOC therapy and relationship to the decrease of platelet counts
journal, February 2011

Walrand, Stephan; Barone, Raffaella; Pauwels, Stanislas
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, Issue 7, p. 1270-1280
https://doi.org/10.1007/s00259-011-1744-x

Conformationally constrained backbone cyclized somatostatin analogs
patent, August 2005

Hornik, Vered; Afargan, Michel; Gellerman, Gary
US Patent Document 6,930,088
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6930088

Peptide compounds having improved binding affinity to somatostatin receptors
patent, October 2006

Macke, Helmut; Reubi, Jean Claude; Schmitt, Jörg
US Patent Document 7,122,622
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7122622

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
journal, February 1998

Nagy, A.; Schally, A. V.; Halmos, G.
Proceedings of the National Academy of Sciences, Vol. 95, Issue 4
https://doi.org/10.1073/pnas.95.4.1794

RAPID COMMUNICATION: Human Ovarian Cancers Express Somatostatin Receptors
journal, October 2000

Halmos, Gabor; Sun, Baodong; Schally, Andrew V.
The Journal of Clinical Endocrinology & Metabolism, Vol. 85, Issue 10
https://doi.org/10.1210/jcem.85.10.3509

Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.
journal, January 1992

Yamada, Y.; Post, S. R.; Wang, K.
Proceedings of the National Academy of Sciences, Vol. 89, Issue 1
https://doi.org/10.1073/pnas.89.1.251

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATATE: the role of associated risk factors
journal, April 2008

Bodei, Lisa; Cremonesi, Marta; Ferrari, Mahila
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Issue 10, p. 1847-1856
https://doi.org/10.1007/s00259-008-0778-1